Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000004

Options or other derivatives

  • Chief Operating Officer acquired 2,198,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Parikh Anand Kiran Chief Operating Officer 2026-02-17 Grant or award · Series B Preferred Stock +809,822 809,822 D
Parikh Anand Kiran Chief Operating Officer 2026-02-17 Grant or award · Employee Stock Option (right to buy) +92,533 92,533 D
Parikh Anand Kiran Chief Operating Officer 2026-02-17 Grant or award · Employee Stock Option (right to buy) +56,673 56,673 D
Parikh Anand Kiran Chief Operating Officer 2026-02-19 Grant or award · Employee Stock Option (right to buy) +1,239,305 1,239,305 D
Loading xslF345X05/form4-02202026_020201.xml…